These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12640974)

  • 21. Alternative consent models for biobanks: the new Spanish law on biomedical research.
    da Rocha AC; Seoane JA
    Bioethics; 2008 Sep; 22(8):440-7. PubMed ID: 18644013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential harms, anonymization, and the right to withdraw consent to biobank research.
    Eriksson S; Helgesson G
    Eur J Hum Genet; 2005 Sep; 13(9):1071-6. PubMed ID: 15986039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Native Hawaiian preferences for informed consent and disclosure of results from genetic research.
    Fong M; Braun KL; Chang RM
    J Cancer Educ; 2006; 21(1 Suppl):S47-52. PubMed ID: 17020502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Communal discourse as a supplement to informed consent for genetic research.
    Foster MW; Eisenbraun AJ; Carter TH
    Nat Genet; 1997 Nov; 17(3):277-9. PubMed ID: 9354789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of informed consent: a pilot study.
    Länsimies-Antikainen H; Pietilä AM; Laitinen T; Schwab U; Rauramaa R; Länsimies E
    J Adv Nurs; 2007 Jul; 59(2):146-54. PubMed ID: 17543012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
    Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
    Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experience with establishment and operation of a biobank].
    Stege A; Hummel M
    Pathologe; 2008 Nov; 29 Suppl 2():214-7. PubMed ID: 18712392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Broad" consent, exceptions to consent and the question of using biological samples for research purposes different from the initial collection purpose.
    Petrini C
    Soc Sci Med; 2010 Jan; 70(2):217-20. PubMed ID: 19853341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does the current consent process minimize the risks of genetics research?
    Wendler D; Prasad K; Wilfond B
    Am J Med Genet; 2002 Dec; 113(3):258-62. PubMed ID: 12439893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regret.
    Stryker JE; Wray RJ; Emmons KM; Winer E; Demetri G
    Patient Educ Couns; 2006 Oct; 63(1-2):104-9. PubMed ID: 16242898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Informed consent and subject motivation to participate in a large, population-based genomics study: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA; Nair A; Austin DM; Giampietro PF
    Community Genet; 2007; 10(1):2-9. PubMed ID: 17167244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics: the bioethical problem of DNA investment banking.
    Corrigan OP; Williams-Jones B
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):550-65. PubMed ID: 16980194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes towards biomedical use of tissue sample collections, consent, and biobanks among Finns.
    Tupasela A; Sihvo S; Snell K; Jallinoja P; Aro AR; Hemminki E
    Scand J Public Health; 2010 Feb; 38(1):46-52. PubMed ID: 19906772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethical issues raised by incorporation of genetics into the National Birth Defects Prevention Study.
    Jenkins MM; Rasmussen SA; Moore CA; Honein MA
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):40-6. PubMed ID: 18189287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment.
    Vermeulen E; Schmidt MK; Aaronson NK; Kuenen M; van der Valk P; Sietses C; van den Tol P; van Leeuwen FE
    J Clin Pathol; 2009 Mar; 62(3):275-8. PubMed ID: 19017681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of biobank constitution and use: multicentre analysis in France and propositions for formalising the activities of research ethics committees.
    de Montgolfier S; Moutel G; Duchange N; Callies I; Sharara L; Beaumont C; Feingold J; Hervé C
    Eur J Med Genet; 2006; 49(2):159-67. PubMed ID: 16530713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical issues arising from the participation of children in genetic research.
    Burke W; Diekema DS
    J Pediatr; 2006 Jul; 149(1 Suppl):S34-8. PubMed ID: 16829241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality assurance questionnaire for professionals fails to improve the quality of informed consent.
    Lavori PW; Wilt TJ; Sugarman J
    Clin Trials; 2007; 4(6):638-49. PubMed ID: 18042573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.